Three Biotechs Bolstered by Positive News
Biotech has been a market laggard lately, but I’m eyeing three companies making recent progress.
Biotech has been a market laggard lately, but I’m eyeing three companies making recent progress.
A jump in yields to fresh multi-year highs cascaded through markets Wednesday.
The stock is in a precarious position but offers some promise.
A sixth day of gains for semiconductors drives the Nasdaq-100 to its first record since June while a fifth day of losses for crude boosted small caps
– $GRML +44% (extends the high-volume Greenland critical-minerals momentum rally)
– $VKTX +25% (positive VK2735 maintenance data showed strong weight loss and high retention with biweekly and monthly dosing)
– $VICR +8.7% (raises Q3 sequential revenue-growth guidance to more than 20% from nearly 10% on V4PD-license royalties)
– $ONON +8.0% (sets high-teens constant-currency sales growth and 22%+ EBITDA-margin targets through 2029 and authorizes a $1B buyback)
– $SHOP +5.1% (no clear fresh catalyst identified; unusually large premarket move in a highly followed stock)
– $RCL +2.4%, CCL +3.0%, NCLH +2.7% (cruise operators rise as crude drops, easing fuel-cost pressure)
– $FSLR +1.8% (rate-sensitive solar shares benefit as Treasury yields retreat)
– $CLDX -20% (positive Phase 3 CSU results trigger a sell-the-news reaction after the anticipated binary readout)
– $DAVA -13% (CFO placed on leave amid an internal accounting investigation disclosed in a 6-K)
– $LH -6.2%, DGX -6.9% (CMS proposes laboratory reimbursement cuts of up to 15% beginning in 2027)
– $VLO -2.1%, $PSX -2.0% (energy names fall as crude drops on easing geopolitical risk)
– $STX -1.4%, WDC -1.4% (storage names pull back with the semiconductor complex after the prior session’s AI-driven rally)
SOURCE: Trade The News